When a parent with dementia becomes agitated, restless, or difficult to redirect, a nursing home may propose an antipsychotic medication to "help them settle." For decades this was routine. It is also one of the most scrutinized practices in long-term care, because these drugs carry a serious safety warning in exactly this population, are frequently used off-label, and can cross the line into a chemical restraint. Families who understand the issue can ask the right questions and protect a loved one from being over-medicated.
What these drugs are and why they're used
Antipsychotics such as risperidone, quetiapine, olanzapine, and haloperidol were developed to treat serious mental illnesses like schizophrenia and bipolar disorder. In nursing homes they are often prescribed instead for the behavioral and psychological symptoms of dementia — agitation, aggression, wandering, calling out, resistance to care. This is an off-label use: it is not an FDA-approved indication for these drugs.
The black box warning
The reason this matters so much is a specific, serious safety finding. The FDA has placed a boxed warning — its most serious type — on antipsychotic drugs, stating that elderly patients with dementia-related psychosis treated with these medications are at an increased risk of death. The drugs are also associated with sedation, falls (themselves a major cause of injury and death in this population), strokes, pneumonia, and a general dulling that can rob a person of what remaining engagement they have. In other words, a medication given to make a person easier to care for can shorten their life and diminish its quality.
Why non-drug approaches come first
The current standard of care — reinforced by a national CMS initiative to reduce unnecessary antipsychotic use in nursing homes — is that behavioral symptoms of dementia should first be addressed by understanding and removing their cause, not by sedating the person. Agitation is often communication: pain that the person can't articulate, hunger, needing the bathroom, boredom, overstimulation, fear, or a disrupted routine. Good dementia care investigates these first.
Evidence-based non-drug approaches include: identifying and treating unrecognized pain (a leading, frequently missed cause of agitation); consistent routines and familiar caregivers; meaningful activity and engagement; adjusting the environment (reducing noise, glare, and overstimulation); music and sensory therapies; and skilled redirection techniques. These take staff time and training, which is part of why sedation is sometimes reached for instead — and part of why understaffing and over-medication tend to travel together.
The line between treatment and chemical restraint
Federal nursing home regulations are explicit: a resident has the right to be free from any psychoactive drug used as a chemical restraint — that is, a medication used to control behavior or restrict movement for the convenience of staff or as discipline, rather than to treat a specific diagnosed medical condition. A sedating drug given to quiet a resident, without a genuine clinical diagnosis the drug is treating, can be a chemical restraint even though no one uses that word. The regulations also require that when antipsychotics are used, there must be an appropriate indication, ongoing monitoring, and gradual dose reduction attempts — meaning the facility must periodically try to lower or stop the drug unless clinically contraindicated, not simply leave the resident on it indefinitely.
Your family's rights
Informed consent. A resident, or their healthcare decision-maker, generally has the right to be informed about a proposed medication — its purpose, its risks (including the boxed warning), and the alternatives — and to consent or decline. Antipsychotics should not simply appear on the medication list. If you learn a parent has been started on one without a clear conversation, that itself is a problem worth raising.
The right to ask what condition is being treated. Ask directly: what specific diagnosed condition is this medication treating, and what non-drug approaches were tried first and why were they insufficient? A clear, specific answer is reassuring; a vague "it helps with the agitation" is a signal to probe further.
The right to monitoring and dose reduction. Ask how the medication's effect and side effects are being monitored, and when the next attempt at gradual dose reduction is scheduled. Ask to be included in care-plan meetings where these decisions are made.
What families should watch for and do
Signs that a loved one may be over-medicated include new or increased sedation, a "zombie-like" flatness, increased falls, confusion beyond their baseline, difficulty eating or swallowing, and a general withdrawal. If you notice these after a medication change, raise it immediately.
Steps to take: Request the complete, current medication list and ask which drugs are psychoactive. For any antipsychotic, ask for the indication, the consent discussion, the monitoring plan, and the gradual-dose-reduction schedule — in writing. Ask to attend the next care-plan meeting. If you believe a drug is being used as a chemical restraint or without proper consent, raise it with the director of nursing and, if unresolved, contact your state's Long-Term Care Ombudsman, who is an independent advocate for residents' rights and can investigate.
The balanced view
None of this means antipsychotics are never appropriate. For some residents with genuine psychosis or severe, dangerous agitation that has not responded to non-drug approaches, a carefully chosen and monitored medication can be the right call, and taking it away can cause harm too. The goal is not zero use; it is appropriate use — driven by a real clinical indication, informed consent, non-drug approaches tried first, careful monitoring, and honest attempts to use the lowest effective dose for the shortest necessary time. Families who ask these questions are not being difficult. They are asking exactly what the standard of care already requires.
Want a clear shortlist before you start calling?
If you don't know which nursing homes to contact first, Curalune Care Help can prepare an ordered shortlist of 3 to 5 suitable options — with contacts, useful links and a ready-to-send message you can put to all of them at once.
The service helps you organise the search. $89, one-off. If you don't receive at least 3 homes matching the area and criteria you gave us, we refund you in full. It does not replace the home's own assessment and does not guarantee admission, price or bed availability.
Important limit
Curalune offers practical help with the search and orientation. Admission, pricing, bed availability and the final assessment always rest with the nursing homes and the competent authorities (your state Medicaid agency, the state survey agency and Medicare).